FDA Adverse Event Other Summary report: N

PLUM A+ DRIVER NEW 8

MDR report key: 1612052 · Received February 18, 2010

Report

Report Number
2921482-2010-00061
Event Type
Other
Date Received
February 18, 2010
Date of Event
January 20, 2010
Report Date
January 21, 2010
Manufacturer
HOSPIRA, INC.
Product Code
FRN
PMA / PMN Number
K042081
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT ISOLATED OR IDENTIFIED BY SERIAL NUMBER; THEREFORE, IT WILL NOT BE RETURNED FOR INVESTIGATION. THE CUSTOMER CONTACT INDICATED THE EVENT WAS THE RESULT OF AN OPERATOR ERROR IN PROGRAMMING THE DEVICE. THIS REPORT REPRESENTS ALL THE INFO KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL; (B)(4).

Description of Event or Problem · 1

THE CUSTOMER CONTACT REPORTED AN OPERATOR ERROR IN PROGRAMMING THE DEVICE, WHICH RESULTED IN THE PT RECEIVING MORE MEDICATION THAN INTENDED. THE PT WAS BEING TREATED IN THE ER WITH A DIAGNOSIS OF CHEST PAIN AND WAS SCHEDULED FOR A CARDIAC CATHETERIZATION. AT 0135, THE DEVICE WAS PROGRAMMED IN THE ML/HR MODE, TO DELIVER HEPARIN 100UNITS/ML, FOR A DOSE OF 768 UNITS/HR, AND THE DELIVERY WAS STARTED. NO FURTHER PROGRAMMING PARAMETERS WERE PROVIDED. AFTER APPROX 10 MINUTES, THE NURSE NOTED THE HEPARIN CONTAINER "APPEARED MORE EMPTY THAN EXPECTED." AT THIS TIME, THE NURSE NOTED THE DEVICE HAD BEEN PROGRAMMED TO DELIVER AT A RATE OF 768 ML/HR (76800 UNITS/HR) INSTEAD OF THE INTENDED DOSE OF 768 UNITS/HR. THE PHYSICIAN WAS NOTIFIED AND ORDERED AN APTT (ACTIVATED PARTIAL THROMBOPLASTIN TIME) LEVEL TO BE DRAWN. THE DEVICE WAS NOT REMOVED FROM CLINICAL SERVICE. THE HEPARIN THERAPY WAS DISCONTINUED. NO FURTHER MEDICAL INTERVENTIONS WERE REQUIRED. THE CUSTOMER CONTACT STATED THE PT HAS "FULLY RECOVERED FROM THE EVENT." ALTHOUGH REQUESTED, NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PLUM A+ DRIVER NEW 8 80FRN FRN HOSPIRA, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 46 YR Required Intervention HEPARIN, MFR HOSPIRA, INC.| PLUM A+ SOFTWARE MODULE, LIST #20791, SN UNK